Dermatological Services

FoLix™ Hair Restoration

FoLix™ is a non-ablative fractional laser system developed for hair loss treatment.

Lumenis describes it as the first FDA-cleared fractional laser for hair loss treatment and positions it as a safe, simple, non-drug approach for women and men.

On its product page, Lumenis states that FoLix™ uses hair stimulation technology and that clinical studies have shown increased hair count and improved scalp hair appearance. A 2025 retrospective observational study is cited on the product page.

How the Technology Works

FoLix™ uses a non-ablative fractional laser approach to create controlled microthermal stimulation in the scalp. Unlike destructive or surgical methods, the treatment is intended to leverage the body’s own regenerative processes without chemicals.

Lumenis describes this as hair stimulation technology, designed to improve scalp hair appearance and support increased hair count through biologic stimulation rather than transplantation or medication delivery alone.

FoLix™ may be considered in patients with hair thinning, reduced density, or patterned hair loss, including common non-scarring alopecia presentations where follicular activity remains present.

Suitability depends on the type of hair loss, scalp condition, chronicity, and whether adjunctive treatment is appropriate.

The scalp is assessed clinically and the treatment area is mapped. Laser energy is then delivered in a controlled fractional pattern across the affected scalp zones.

Depending on the protocol, adjunctive topical measures may be incorporated into the broader treatment plan, although the platform itself is promoted as a non-chemical stimulation approach.

Treatment courses typically involve repeated sessions rather than a single visit, as hair cycling biology requires time and repeated stimulation.

Potential benefits include improvement in overall scalp hair appearance, support of hair density, and an increase in hair count in appropriate candidates.

Because FoLix™ is non-surgical and non-drug based, it may be attractive for patients seeking a device-based approach or as part of a combined medical hair restoration plan. Lumenis specifically states that clinical studies show increased hair count and improvement in scalp hair appearance.

Before and After Care

Before Treatment

The scalp should be clean and free of active inflammatory disease, open lesions, or untreated infection. Patients should disclose hair-loss duration, prior treatments, use of oral or topical therapies, and any history suggestive of scarring alopecia or systemic causes of shedding.

In hair restoration, diagnosis is particularly important because different causes of hair loss do not respond equally to the same treatment.

After treatment, mild erythema or scalp sensitivity may occur temporarily.

Patients are generally advised to avoid unnecessary irritation of the scalp immediately after the session and to follow any individualized instructions regarding washing, topical products, or adjunctive hair therapies.

Risks and Side Effects

Possible temporary effects include redness, warmth, mild tenderness, and short-lived sensitivity of the treated scalp. As with any energy-based treatment, response varies by indication and hair-loss type.

A consultation is essential not only for safety, but also to determine whether the diagnosis is suitable for a laser-based hair restoration protocol.

A medical consultation is required to identify the type of alopecia, assess scalp health, and determine whether FoLix™ should be used alone or in combination with other therapies.

Hair restoration usually requires a staged treatment plan. Pricing is determined after consultation.